Anhui BBCA Pharmaceutical

Anhui BBCA Pharmaceutical, also known as Anhui Fengyuan Pharmaceutical, is a leading Chinese pharmaceutical company engaged in the research, development, manufacturing, and sale of a wide range of medical products. The company specializes in large-volume parenteral solutions (infusions), small-volume injections, and various solid dosage forms including tablets and capsules. Its product portfolio covers therapeutic areas such as cardiovascular health, anti-infectives, and metabolic disorders. As a key subsidiary of the BBCA Group, the company maintains significant manufacturing infrastructure and a robust distribution network across China and international markets.